A carregar...

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab

PURPOSE: To report the 12-month outcomes of a patient switching from intravitreal ranibizumab to aflibercept for choroidal neovascularization (CNV) associated with angioid streaks (AS). RESULTS: A 42-year-old Caucasian female with CNV associated with AS underwent intensive treatment with ranibizumab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Med Case Rep J
Main Authors: Makri, Olga E, Tsapardoni, Foteini N, Plotas, Panagiotis, Pallikari, Athina, Georgakopoulos, Constantine D
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149836/
https://ncbi.nlm.nih.gov/pubmed/30271222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S166473
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!